The therapeutic effect of highly malignant triple negative breast cancer (TNBC) is negatively
affected by the formation of tumor cell resistant clone and the severe toxicity of …

Triple-negative breast cancer (TNBC) cells are deficient in estrogen, progesterone and
ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to …

Triple-negative breast cancer (TNBC) is a kind of breast cancer that lacks estrogen,
progesterone, and human epidermal growth factor receptor 2. This cancer is responsible for …

It has become necessary to accept the clinical reality of therapeutic agents targeting the
cancer-associated immune system. In recent decades, several investigations have …

Nanoscale materials have been explored extensively as agents for therapeutic and
diagnostic (ie, theranostic) applications. Research efforts have shifted from exploring new …

Chemotherapy is still the most direct and effective means of cancer therapy nowadays. The
proposal of drug delivery systems (DDSs) has effectively improved many shortcomings of …

Standard cancer treatments involve surgery, radiotherapy, chemotherapy, and
immunotherapy. In clinical practice, the respective drugs are applied orally or intravenously …

Abstracts The phenomenal rise in cancer over the past few years has made it the second
leading cause of death worldwide. Breast cancer constitutes the predominant cancer …

Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

Polysaccharides, an important class of biological polymers, are effectively bioactive,
nontoxic, hydrophilic, biodegradable and offer a wide diversity in structure and properties …